Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001829126-22-017978
Filing Date
2022-10-17
Accepted
2022-10-14 17:55:53
Documents
57
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-K globalwholehealth_10k.htm   iXBRL 10-K 1025388
2 EXHIBIT 10.12 globalwholehealth_ex10-12.htm EX-10.12 69652
3 EXHIBIT 10.13 globalwholehealth_ex10-13.htm EX-10.13 82444
4 EXHIBIT 10.14 globalwholehealth_ex10-14.htm EX-10.14 192978
5 EXHIBIT 10.15 globalwholehealth_ex10-15.htm EX-10.15 188346
6 EXHIBIT 31.1 globalwholehealth_ex31-1.htm EX-31.1 11457
7 EXHIBIT 32.1 globalwholehealth_ex32-1.htm EX-32.1 5128
13 GRAPHIC ex10-15_001.jpg GRAPHIC 23187
  Complete submission text file 0001829126-22-017978.txt   5354457

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE gwhp-20220630.xsd EX-101.SCH 41229
9 XBRL CALCULATION FILE gwhp-20220630_cal.xml EX-101.CAL 39541
10 XBRL DEFINITION FILE gwhp-20220630_def.xml EX-101.DEF 147042
11 XBRL LABEL FILE gwhp-20220630_lab.xml EX-101.LAB 276788
12 XBRL PRESENTATION FILE gwhp-20220630_pre.xml EX-101.PRE 232939
51 EXTRACTED XBRL INSTANCE DOCUMENT globalwholehealth_10k_htm.xml XML 590655
Mailing Address 1130 CALLE CORDILLERA SAN CLEMENTE CA 92673
Business Address 1130 CALLE CORDILLERA SAN CLEMENTE CA 92673 (714) 392-4112
Global Wholehealth Partners Corp (Filer) CIK: 0001598308 (see all company filings)

EIN.: 462316220 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 000-56035 | Film No.: 221312126
SIC: 2835 In Vitro & In Vivo Diagnostic Substances